Time-restricted eating helped women with PCOS lose weight, no more than calorie cutting
In a 76-woman randomised trial, a six-hour daily eating window and standard calorie restriction each produced about a 4% weight loss over six months, with no advantage for either approach.
| Group | Value (%) |
|---|---|
| Time-restricted eating | 4.32 |
| Calorie restriction | 4.66 |
Losing weight is notoriously hard for women with polycystic ovary syndrome, the most common hormonal disorder of reproductive age, and even modest weight loss can ease its symptoms. Time-restricted eating, squeezing all food into a narrow daily window without counting calories, has become a popular shortcut. A randomised trial in Nature Medicine tested whether it actually beats the standard advice of eating less, and the honest answer is that it does not [s1].
What the trial tested
Researchers randomly assigned 76 women with PCOS to one of three groups for six months [s1]. One followed a six-hour eating window, consuming all their meals between 1pm and 7pm with no instruction to track or cut calories [s1]. A second followed conventional daily calorie restriction, cutting energy intake by 25% [s1]. A third made no dietary changes and served as the control [s1]. The primary outcome was the percentage change in body weight at six months, and the trial was registered as NCT05629858 [s1].
The design is worth noting. Comparing a fashionable eating pattern against both an established diet and a do-nothing control is the fair test: it shows not just whether time-restricted eating works, but whether the clock adds anything beyond simply eating less.
What it found
Both diets worked, and worked about equally. Body weight fell by 4.32% in the time-restricted group (95% confidence interval -6.20 to -2.44; P<0.01) and by 4.66% in the calorie-restriction group (-7.13 to -2.19; P<0.01), each significantly more than the control group [s1]. The difference between the two diets was trivial and not significant: 0.34% (-2.15 to 2.83; P=0.79) [s1]. No serious adverse events were reported in any group [s1].
In plain terms, restricting the hours you eat produced the same weight loss as restricting the calories you eat. That is a genuinely useful finding, because for some people a time window is easier to follow than weighing portions or logging every meal. The mechanism, though, is almost certainly the same: people who eat only within six hours tend to eat less overall, even when no one tells them to count. The clock is a means to a calorie deficit, not a separate metabolic lever, and the trial's near-identical results in the two diet groups are exactly what that reading predicts [s1].
Where this fits
International PCOS guidance, updated in 2023 across professional and consumer organisations and running to 254 formal recommendations, frames healthy lifestyle and weight management as foundational to care rather than an optional extra [s2]. Within that framework, the new trial does not overturn anything; it fills in a practical detail. It tells clinicians and patients that if the goal is weight loss, they can reasonably offer whichever approach the woman is more likely to stick with, because the scale does not appear to care which one she picks [s1][s2].
How to read it
Three cautions keep this in proportion. First, the trial was small, with 76 participants split three ways, so it can speak to average weight change but not reliably to less common outcomes or to differences between subgroups of women [s1]. Second, it ran for six months; time-restricted eating's real test is whether people can sustain a compressed window for years, and short trials cannot answer that [s1]. Third, the primary outcome was body weight, not the reproductive and metabolic features, such as menstrual regularity, insulin resistance or androgen levels, that matter most to many women with PCOS [s1]. A roughly 4% weight loss is meaningful and can improve those features, but this trial measured the weight, not the downstream benefits [s1].
There is also a safety nuance that trials of eating windows rarely dwell on. Very restricted eating patterns are not advisable for everyone, including people with a history of disordered eating, those who are pregnant or trying to conceive, and anyone on medication that must be taken with food. For women with PCOS who are actively pursuing pregnancy, the priority is a sustainable, nourishing pattern rather than the narrowest possible window.
The liftable summary: in women with PCOS, a six-hour eating window and a standard 25% calorie cut each produced about a 4% weight loss over six months, with neither beating the other [s1]. Time-restricted eating is a legitimate option for those who find it easier to follow, but it is not a magic bullet, and it earns its place by being simpler to stick to, not by doing anything the old advice could not.
This article is informational and is not medical advice. Dietary changes for PCOS should be discussed with a clinician or dietitian.
Sources
- [s1] Time-restricted eating for body weight management in women with polycystic ovary syndrome: a randomized controlled trial. Nature Medicine, 27 March 2026; 32(6):2155-2163. ClinicalTrials.gov NCT05629858. https://doi.org/10.1038/s41591-026-04316-7
- [s2] Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility, 14 August 2023. https://doi.org/10.1016/j.fertnstert.2023.07.025
Sources
- Time-restricted eating for body weight management in women with polycystic ovary syndrome: a randomized controlled trial — Nature Medicine , March 27, 2026
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome — Fertility and Sterility , August 14, 2023
More on
Tirzepatide drove nearly 20% weight loss in women with PCOS, a UK service reports
A retrospective analysis of 54,114 women on a digital weight-loss service found those with PCOS lost as much as those without. But only 40 PCOS users reached the 10-month mark, and the data are observational.
Vitamin D before IVF raised blood levels and left live birth rates unchanged
An 876-participant double-blind trial across 24 Chinese fertility centres nearly doubled serum 25-OHD in women with PCOS. Live births were 52.0% against 50.2% on placebo.
Letrozole beat clomiphene for live births in PCOS, the trial that reset first-line care
A double-blind trial randomised 750 women with polycystic ovary syndrome to one drug or the other. Letrozole produced more live births and more ovulation — and is now the guideline's first choice for fertility.
Weight loss helped older atrial-fibrillation patients lose weight, but not their symptoms
In the LOSE-AF trial, an eight-month low-calorie programme cut weight by 9.7% in older adults with AF. It did not change their symptoms, their AF burden, or their need for further rhythm treatment.